|
ALG11 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.81040000055444E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.6561000004689E-07 |
| Normal-vs-Stage2 |
6.171500E-04 |
| Normal-vs-Stage3 |
2.581000E-03 |
| Normal-vs-Stage4 |
1.586310E-02 |
| Stage1-vs-Stage2 |
9.061000E-01 |
| Stage1-vs-Stage3 |
2.652600E-01 |
| Stage1-vs-Stage4 |
2.367400E-01 |
| Stage2-vs-Stage3 |
4.593200E-01 |
| Stage2-vs-Stage4 |
3.746600E-01 |
| Stage3-vs-Stage4 |
8.406000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.19819999986082E-07 |
| Normal-vs-AfricanAmerican |
1.737980E-02 |
| Normal-vs-Asian |
1.219220E-01 |
| Caucasian-vs-AfricanAmerican |
3.700600E-01 |
| Caucasian-vs-Asian |
3.187400E-01 |
| AfricanAmerican-vs-Asian |
5.755800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.57699999999905E-05 |
| Normal-vs-Female |
2.07250000050507E-07 |
| Male-vs-Female |
1.593980E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.656600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.91810000052628E-07 |
| Normal-vs-Age(61-80Yrs) |
4.53570000003012E-06 |
| Normal-vs-Age(81-100Yrs) |
2.967600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.024260E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.507600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.674600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.734840E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.550400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.954400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.87230000000028E-05 |
| Normal-vs-Grade 2 |
2.37289999982515E-07 |
| Normal-vs-Grade 3 |
4.45479999999776E-06 |
| Normal-vs-Grade 4 |
2.441400E-01 |
| Grade 1-vs-Grade 2 |
4.577600E-01 |
| Grade 1-vs-Grade 3 |
4.254200E-01 |
| Grade 1-vs-Grade 4 |
5.800400E-02 |
| Grade 2-vs-Grade 3 |
7.620400E-01 |
| Grade 2-vs-Grade 4 |
1.516440E-02 |
| Grade 3-vs-Grade 4 |
1.513600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.50930000053506E-07 |
| Normal-vs-ccB subtype |
1.232790E-04 |
| ccA subtype-vs-ccB subtype |
9.305800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.89430000000035E-06 |
| Normal-vs-N1 |
5.294600E-01 |
| N0-vs-N1 |
2.511400E-01 |
|
|
